radiotherapy

You have access
Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer
DIRK RADES, TRANG NGUYEN and STEVEN E. SCHILD

In Vivo May 2020, 34 (3) 1321-1324; DOI: https://doi.org/10.21873/invivo.11908
You have access
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study
VITALIANA DE SANCTIS, ALICE DI ROCCO, MARIA CHRISTINA COX, MAURIZIO VALERIANI, FRANCESCA PERRONE CONGEDI, DIMITRI ANZELLINI, MARIA MASSARO, GIANLUCA VULLO, GIUSEPPE FACONDO, FLAVIA DE GIACOMO, MARCO ALFÒ, DANIELA PROSPERI, PATRIZIA PIZZICHINI, SABRINA PELLICCIA, AGOSTINO TAFURI, MAURIZIO MARTELLI and MATTIA FALCHETTO OSTI

In Vivo May 2020, 34 (3) 1407-1413; DOI: https://doi.org/10.21873/invivo.11921
You have access
Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate Cancer
FELIX ZWICKER, BENEDICT SWARTMAN, PETER E. HUBER, KLAUS HERFARTH, JÜRGEN DEBUS and HENRIK HAUSWALD

In Vivo May 2020, 34 (3) 1555-1563; DOI: https://doi.org/10.21873/invivo.11945
You have access
Xerostomia and Clinical Outcomes in Definitive Intensity Modulated Radiotherapy (IMRT) Versus Three-dimensional Conformal Radiotherapy (3D-CRT) for Head and Neck Squamous Cell Carcinoma: A Meta-analysis
FRANCESCA DE FELICE, NICOLA PRANNO, PIERO PAPI, ORLANDO BRUGNOLETTI, VINCENZO TOMBOLINI and ANTONELLA POLIMENI

In Vivo March 2020, 34 (2) 623-629; DOI: https://doi.org/10.21873/invivo.11816
You have access
Symptom Burden in Patients With Reduced Performance Status at the Start of Palliative Radiotherapy
CARSTEN NIEDER and THOMAS A. KÄMPE

In Vivo March 2020, 34 (2) 735-738; DOI: https://doi.org/10.21873/invivo.11832
You have access
Clinical Outcomes of Dose-escalated Radiotherapy for Localised Prostate Cancer: A Single-institution Experience
KATHERINE MENG, KEITH LIM, CHIA CHING LEE, DAVID CHIA, KIAT HUAT OOI, YU YANG SOON and JEREMY TEY

In Vivo March 2020, 34 (2) 757-765; DOI: https://doi.org/10.21873/invivo.11835
You have access
Interval Between Cancer Diagnosis and Radiotherapy – An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer
DIRK RADES, RAPHA HAUS, STEFAN JANSSEN and STEVEN E. SCHILD

In Vivo March 2020, 34 (2) 767-770; DOI: https://doi.org/10.21873/invivo.11836
You have access
Low-grade Fibromyxoid Sarcoma: Treatment Outcomes and Efficacy of Chemotherapy
FLORENCE CHAMBERLAIN, BODIL ENGELMANN, OMAR AL-MUDERIS, CHRISTINA MESSIOU, KHIN THWAY, AISHA MIAH, SHANE ZAIDI, ANASTASIA CONSTANTINIDOU, CHARLOTTE BENSON, SPYRIDON GENNATAS and ROBIN L. JONES

In Vivo January 2020, 34 (1) 239-245; DOI: https://doi.org/10.21873/invivo.11766
You have access
Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung Adenocarcinoma
TAKAAKI NAKASHIMA, TAKESHI NONOSHITA, HIDENARI HIRATA, KOUJI INOUE, AKIRA NAGASHIMA, TADAMASA YOSHITAKE, KAORI ASAI and YOSHIYUKI SHIOYAMA

In Vivo January 2020, 34 (1) 247-253; DOI: https://doi.org/10.21873/invivo.11767
You have access
E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy
PINELOPI GKOGKOU, EVANGELIA PEPONI, DIMITRIOS NTASKAGIANNIS, SAMUEL MURRAY, ASIMO DEMOU, IOANNIS SAINIS, ELLI IOAKEIM, EVANGELOS BRIASOULIS and PERICLES TSEKERIS

In Vivo January 2020, 34 (1) 453-459; DOI: https://doi.org/10.21873/invivo.11795

Main menu

User menu

Search

radiotherapy

Pages